Janssen Announces U.S. FDA Approval of Novel TREMFYA ® (guselkumab) One-Press Patient-controlled Injector for Adults with Moderate-to-Severe Plaque Psoriasis

Source: Johnson and Johnson - Category: Pharmaceuticals Source Type: news